Literature DB >> 15692560

Suppression of FOXO1 activity by FHL2 through SIRT1-mediated deacetylation.

Yonghua Yang1, Huayan Hou, Edward M Haller, Santo V Nicosia, Wenlong Bai.   

Abstract

Forkhead box class O (FOXO) proteins are transcription factors that function downstream of the PTEN tumor suppressor and directly control the expression of genes involved in apoptosis, cell cycle progression, and stress responses. In the present study, we show that FOXO1 interacts with four and a half LIM 2 (FHL2) in prostate cancer cells. This interaction occurred in the nucleus and was enhanced by lysophosphatic acid. FHL2 decreased the transcriptional activity of FOXO1 and the expression of known FOXO target genes and inhibited FOXO1-induced apoptosis. Interestingly, SIRT1, a mammalian homolog of yeast Sir2, bound to and deacetylated FOXO1 and inhibited its transcriptional activity. FHL2 enhanced the interaction of FOXO1 and SIRT1 and the deacetylation of FOXO1 by Sirtuin-1 (SIRT1). Overall, our data show that FHL2 inhibits FOXO1 activity in prostate cancer cells by promoting the deacetylation of FOXO1 by SIRT1.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15692560      PMCID: PMC554122          DOI: 10.1038/sj.emboj.7600570

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  48 in total

1.  AKT-independent protection of prostate cancer cells from apoptosis mediated through complex formation between the androgen receptor and FKHR.

Authors:  Pengfei Li; Heehyoung Lee; Shaodong Guo; Terry G Unterman; Guido Jenster; Wenlong Bai
Journal:  Mol Cell Biol       Date:  2003-01       Impact factor: 4.272

2.  Identification of the LIM protein FHL2 as a coactivator of beta-catenin.

Authors:  Yu Wei; Claire-Angélique Renard; Charlotte Labalette; Yuanfei Wu; Laurence Lévy; Christine Neuveut; Xavier Prieur; Marc Flajolet; Sylvie Prigent; Marie-Annick Buendia
Journal:  J Biol Chem       Date:  2002-12-03       Impact factor: 5.157

3.  A novel mechanism of gene regulation and tumor suppression by the transcription factor FKHR.

Authors:  Shivapriya Ramaswamy; Noriaki Nakamura; Isabelle Sansal; Louise Bergeron; William R Sellers
Journal:  Cancer Cell       Date:  2002-07       Impact factor: 31.743

4.  The LIM-only protein FHL2 is a serum-inducible transcriptional coactivator of AP-1.

Authors:  Aurore Morlon; Paolo Sassone-Corsi
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-18       Impact factor: 11.205

5.  Deciphering the transcriptional histone acetylation code for a human gene.

Authors:  Theodora Agalioti; Guoying Chen; Dimitris Thanos
Journal:  Cell       Date:  2002-11-01       Impact factor: 41.582

6.  The transcriptional coactivator FHL2 transmits Rho signals from the cell membrane into the nucleus.

Authors:  Judith M Müller; Eric Metzger; Holger Greschik; Anja-Katrin Bosserhoff; Luka Mercep; Reinhard Buettner; Roland Schüle
Journal:  EMBO J       Date:  2002-02-15       Impact factor: 11.598

7.  hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase.

Authors:  H Vaziri; S K Dessain; E Ng Eaton; S I Imai; R A Frye; T K Pandita; L Guarente; R A Weinberg
Journal:  Cell       Date:  2001-10-19       Impact factor: 41.582

8.  Negative regulation of forkhead transcription factor AFX (Foxo4) by CBP-induced acetylation.

Authors:  Masahiro Fukuoka; Hiroaki Daitoku; Mitsutoki Hatta; Hitomi Matsuzaki; Satoshi Umemura; Akiyoshi Fukamizu
Journal:  Int J Mol Med       Date:  2003-10       Impact factor: 4.101

9.  Insulin-regulated hepatic gluconeogenesis through FOXO1-PGC-1alpha interaction.

Authors:  Pere Puigserver; James Rhee; Jerry Donovan; Christopher J Walkey; J Cliff Yoon; Francesco Oriente; Yukari Kitamura; Jennifer Altomonte; Hengjiang Dong; Domenico Accili; Bruce M Spiegelman
Journal:  Nature       Date:  2003-05-18       Impact factor: 49.962

10.  Cell cycle inhibition by FoxO forkhead transcription factors involves downregulation of cyclin D.

Authors:  Marc Schmidt; Silvia Fernandez de Mattos; Armando van der Horst; Rob Klompmaker; Geert J P L Kops; Eric W-F Lam; Boudewijn M T Burgering; René H Medema
Journal:  Mol Cell Biol       Date:  2002-11       Impact factor: 4.272

View more
  139 in total

Review 1.  Protective effects and mechanisms of sirtuins in the nervous system.

Authors:  Feng Zhang; Suping Wang; Li Gan; Peter S Vosler; Yanqin Gao; Michael J Zigmond; Jun Chen
Journal:  Prog Neurobiol       Date:  2011-09-10       Impact factor: 11.685

Review 2.  Sirtuins in neurodegenerative diseases: a biological-chemical perspective.

Authors:  Aparna Raghavan; Zahoor A Shah
Journal:  Neurodegener Dis       Date:  2011-10-28       Impact factor: 2.977

3.  SIRT1 is a Highly Networked Protein That Mediates the Adaptation to Chronic Physiological Stress.

Authors:  Michael W McBurney; Katherine V Clark-Knowles; Annabelle Z Caron; Douglas A Gray
Journal:  Genes Cancer       Date:  2013-03

4.  SIRT1 top 40 hits: use of one-bead, one-compound acetyl-peptide libraries and quantum dots to probe deacetylase specificity.

Authors:  Adam L Garske; John M Denu
Journal:  Biochemistry       Date:  2006-01-10       Impact factor: 3.162

Review 5.  Looking for putative functions of the Leishmania cytosolic SIR2 deacetylase.

Authors:  D Sereno; B Vergnes; F Mathieu-Daude; A Cordeiro da Silva; A Ouaissi
Journal:  Parasitol Res       Date:  2006-09-20       Impact factor: 2.289

Review 6.  Insulin signaling, resistance, and the metabolic syndrome: insights from mouse models into disease mechanisms.

Authors:  Shaodong Guo
Journal:  J Endocrinol       Date:  2014-01-08       Impact factor: 4.286

7.  Role of sirtuin histone deacetylase SIRT1 in prostate cancer. A target for prostate cancer management via its inhibition?

Authors:  Brittney Jung-Hynes; Minakshi Nihal; Weixiong Zhong; Nihal Ahmad
Journal:  J Biol Chem       Date:  2008-12-15       Impact factor: 5.157

8.  A potent and selective Sirtuin 1 inhibitor alleviates pathology in multiple animal and cell models of Huntington's disease.

Authors:  Marianne R Smith; Adeela Syed; Tamas Lukacsovich; Judy Purcell; Brett A Barbaro; Shane A Worthge; Stephen R Wei; Giuseppe Pollio; Letizia Magnoni; Carla Scali; Luisa Massai; Davide Franceschini; Michela Camarri; Marco Gianfriddo; Enrica Diodato; Russell Thomas; Ozgun Gokce; S J Tabrizi; Andrea Caricasole; Bernard Landwehrmeyer; Liliana Menalled; Carol Murphy; Sylvie Ramboz; Ruth Luthi-Carter; Goran Westerberg; J Lawrence Marsh
Journal:  Hum Mol Genet       Date:  2014-01-16       Impact factor: 6.150

9.  Fhl2 deficiency results in osteopenia due to decreased activity of osteoblasts.

Authors:  Thomas Günther; Cecilia Poli; Judith M Müller; Philip Catala-Lehnen; Thorsten Schinke; Na Yin; Sandra Vomstein; Michael Amling; Roland Schüle
Journal:  EMBO J       Date:  2005-08-04       Impact factor: 11.598

10.  AG1031 induces apoptosis through suppressing SIRT1/p53 pathway in human neuroblastoma cells.

Authors:  Jingxuan Fu; Hui Zhang; Yuling Zhang; Tao Zhang
Journal:  Mol Cell Biochem       Date:  2018-10-22       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.